BackAmryt Pharma Plc Overview

Amryt Pharma Plc Other Liabilities

Track Amryt Pharma Plc's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Amryt Pharma Plc Other Liabilities History

Loading

Amryt Pharma Plc vs. peers: Other Liabilities Comparison

Loading

Amryt Pharma Plc Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Amryt Pharma Plc (AMYT) FAQ

Amryt Pharma Plc (AMYT) currently reports a other liabilities of $0 as of April 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Amryt Pharma Plc's other liabilities history and peer comparisons.

Amryt Pharma Plc's other liabilities changed from $0 to $0 (period ending April 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Amryt Pharma Plc reported $0 in other liabilities as of April 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amryt Pharma Plc, and consider following AMYT for alerts when major investors trade the stock.

Amryt Pharma Plc is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMYT with unrelated industries.